FDA permanently removes in-person dispensing requirement for mifepristone

The FDA finalized changes to mifepristone dispensing rules, permanently allowing certified pharmacies to dispense the drug and patients to receive it through telehealth prescriptions and mail delivery. The changes followed a temporary COVID-19 pandemic waiver that the Biden administration made permanent. Telehealth abortion clinics expanded rapidly, becoming the primary access point for medication abortion in states with clinic restrictions.